Search for: "U.S. v. Janssen"
Results 41 - 60
of 117
Sorted by Relevance
|
Sort by Date
12 Aug 2014, 8:00 pm
Janssen Biotech, Inc., No. 2013-1338, 1346 (Fed. [read post]
25 Apr 2017, 3:00 am
The U.S. [read post]
23 Mar 2011, 5:02 am
Jurors also found that J&J warning label information on Risperdal was deceptive.The state’s case centered on drug-safety claims that New Brunswick, New Jersey-based J&J and Janssen made in November 2003 correspondence to about 700,000 doctors across the U.S., including 7,200 in South Carolina.The U.S. [read post]
31 Jan 2015, 8:32 am
The case is PP v. [read post]
27 Oct 2021, 5:15 am
Janssen Pharmaceutica, N.V., No. 21-202 (NHK-Fintiv rule for denying petitions; appealability of IPR petition denial); Apple Inc. v. [read post]
23 Oct 2009, 4:12 pm
In In re ‘318 Patent Infringement Litigation (Janssen Pharmaceutica N.V. v. [read post]
14 Dec 2021, 9:57 am
Janssen and Apple v. [read post]
18 Jun 2007, 4:26 pm
Janssen Pharmaceutica Products LLP and Alza Corporation, CA No. 05-8116, U.S. [read post]
23 Jul 2020, 8:00 am
Janssen, 394 N.E.2d 721, 723 (Ill. [read post]
16 Jan 2010, 7:09 am
In Gentile v. [read post]
5 Mar 2014, 2:46 pm
Wyeth LLC, U.S. [read post]
10 Nov 2011, 7:16 pm
Ltd. v. [read post]
12 Jan 2010, 8:08 am
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
25 Mar 2009, 5:09 am
Janssen, 426 Pa. [read post]
3 Mar 2015, 7:43 am
The case is PP v. [read post]
7 Oct 2013, 7:12 am
Janssen Phamaceutica Products, L.P. [read post]
7 Oct 2013, 7:12 am
Janssen Phamaceutica Products, L.P. [read post]
6 Jun 2011, 6:12 am
Sales of the drug fell to $527 million last year, according to a January earnings report.Risperdal Consta, the long-acting version of the antipsychotic drug, generated $1.5 billion in sales last year for J&J.The state’s case centered on drug-safety claims that J&J and Janssen made in November 2003 correspondence to about 700,000 doctors across the U.S., including more than 7,000 in South Carolina.The U.S. [read post]
6 Oct 2017, 2:34 pm
Janssen Biotech Inc., 759 F.3d 1285 (Fed. [read post]
6 Oct 2017, 2:34 pm
Janssen Biotech Inc., 759 F.3d 1285 (Fed. [read post]
